Modelling hepatitis C transmission over a social network of injecting drug users

► We model the spread of HCV on an empirical social network of injecting drug users. ► The empirical network provides some protective effect on time to primary infection. ► We explore the reduced risk from a gateway node with oscillating disease status. ► Our estimate of per-event transmission probability agrees with previous estimates.